JP Patent

JP2021011487A — 胎児又は小児の鉄欠乏症の治療のための鉄炭水化物複合体

Assigned to Pharmacosmos Holding AS · Expires 2021-02-04 · 5y expired

What this patent protects

【課題】胎児又は小児の鉄欠乏症の治療又は予防における使用のための薬学的組成物の提供。【解決手段】胚、胎児又は小児の鉄含有量を増加させるために、鉄炭水化物複合体が胎児又は小児の母親に投与される。【選択図】図１

USPTO Abstract

【課題】胎児又は小児の鉄欠乏症の治療又は予防における使用のための薬学的組成物の提供。【解決手段】胚、胎児又は小児の鉄含有量を増加させるために、鉄炭水化物複合体が胎児又は小児の母親に投与される。【選択図】図１

Drugs covered by this patent

Patent Metadata

Patent number
JP2021011487A
Jurisdiction
JP
Classification
—
Expires
2021-02-04
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacosmos Holding AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.